A detailed history of Jpmorgan Chase & CO transactions in Pet Iq, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 25,210 shares of PETQ stock, worth $781,005. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,210
Previous 31,964 21.13%
Holding current value
$781,005
Previous $584,000 4.79%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$15.93 - $22.26 $107,591 - $150,344
-6,754 Reduced 21.13%
25,210 $556,000
Q1 2024

May 10, 2024

BUY
$15.55 - $19.42 $129,251 - $161,419
8,312 Added 35.14%
31,964 $584,000
Q4 2023

Feb 12, 2024

SELL
$17.18 - $22.38 $9,500 - $12,376
-553 Reduced 2.28%
23,652 $467,000
Q3 2023

Nov 14, 2023

BUY
$15.0 - $20.71 $32,685 - $45,127
2,179 Added 9.89%
24,205 $476,000
Q2 2023

Aug 11, 2023

BUY
$10.84 - $15.43 $943 - $1,342
87 Added 0.4%
22,026 $334,000
Q1 2023

May 18, 2023

BUY
$9.32 - $12.58 $193,567 - $261,274
20,769 Added 1775.13%
21,939 $250,000
Q1 2023

May 11, 2023

SELL
$9.32 - $12.58 $148,952 - $201,053
-15,982 Reduced 93.18%
1,170 $13,000
Q4 2022

Feb 13, 2023

SELL
$6.82 - $12.07 $2,577 - $4,562
-378 Reduced 2.16%
17,152 $158,000
Q3 2022

Nov 14, 2022

BUY
$6.9 - $18.16 $10,212 - $26,876
1,480 Added 9.22%
17,530 $121,000
Q2 2022

Aug 11, 2022

BUY
$14.09 - $25.12 $45,017 - $80,258
3,195 Added 24.85%
16,050 $270,000
Q1 2022

May 11, 2022

BUY
$17.92 - $24.4 $19,443 - $26,474
1,085 Added 9.22%
12,855 $314,000
Q4 2021

Feb 10, 2022

SELL
$19.97 - $25.91 $383,503 - $497,575
-19,204 Reduced 62.0%
11,770 $267,000
Q3 2021

Nov 12, 2021

BUY
$23.99 - $38.59 $743,066 - $1.2 Million
30,974 New
30,974 $774,000

Others Institutions Holding PETQ

About PetIQ, Inc.


  • Ticker PETQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,312,800
  • Market Cap $908M
  • Description
  • PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...
More about PETQ
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.